Navigation mit Access Keys

Search


Kältespezialist (m/w), 80-100%

Per 1 Januar 2025 oder nach Vereinbarung Das Biozentrum der Universität Basel ist eines der weltweit führenden Institute für Life Sciences. Mit 32 Gruppen und rund 500 Mitarbeitenden sind wir eine dynamische und…


Franz Grün

Prof. Dr. Franz Grün, Emeritus 1972 - 1980 | Professor of Pharmacology Franz Grün studied physical chemistry at the University of Basel and graduated with a doctorate in the field of pharmacology under the guidance of Prof.…


CV

CV of Prof. Attila Becskei ORCID 0000-0002-9462-0934 Nationality : Hungarian Positions: Since 2011 Professor, Biozentrum, University of Basel, Switzerland 2006 – 2011 Assistant Professor, University of Zurich, Switzerland…


Video

Video SRF broadcast Einstein, April 25, 2019 "The truth behind movement - why sport is so important" With a contribution by Prof. Christoph Handschin, Biozentrum, University of Basel The SRF broadcast Einstein explored…


Spread of a novel SARS-CoV-2 variant across Europe in summer 2020

In Europe alone, hundreds of different variants of the new coronavirus SARS-CoV-2 are currently circulating, distinguished by mutations in their genomes. However, only very few of these variants have spread as successfully…


Team

The Team Prof. Markus Rüegg, PhD, CEO and Member of the Board Training in biochemistry and neurosciences Proven track record in neuromuscular research Full Professor for neurobiology Thomas Meier, PhD Chairman of the Board…


Science Prize for Sebastian Hiller

The structure of a protein reveals a lot about its function. This means, the more precisely the three-dimensional protein structure is known, the better the conclusions on its function can be drawn. Using NMR spectroscopy,…


Diversity in the brain – How millions of neurons become unique

The brain is our body’s most complex organ and consists of about 100 billion neurons. For the error-free transmission of information and for proper functioning, the different cells must be programmed in a way that they…


T3 Pharma: Lead product expected to enter clinical phase

“We are very pleased to be joined by two experienced and specialised investors, the Boehringer Ingelheim Venture Fund and Reference Capital SA. This is optimal for completing preclinical work, and for planning and conducting…


How brain tumors promote their own growth

Cancer cells are characterized by uncontrolled growth and cell division. A glioblastoma is a particularly aggressive form of brain tumor, which results from uncontrolled growth of so-called glial cells. Glial cells surround…